SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-02-018693
Filing Date
2002-05-07
Accepted
2002-05-06 19:19:54
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a2078996zsc13d.htm SC 13D 58624
3 EXHIBIT 1 a2078996zex-1.htm EX-1 9929
4 EXHIBIT 2 a2078996zex-2.htm EX-2 4248
  Complete submission text file 0000912057-02-018693.txt   75170
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

IRS No.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-78237 | Film No.: 02635564
SIC: 2834 Pharmaceutical Preparations